Chemotherapy for relapsed small cell lung cancer: a clinical practice guideline
Susanna Yee-Shan Cheng, W.K. Evans, Denise Stys‐Norman et al. · 2006
Cited by 10 works.
Authors
References
- A Southwest Oncology Group study
- Topotecan Versus Cyclophosphamide, Doxorubicin, and Vincristine for the Treatment of Recurrent Small-Cell Lung Cancer
- The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation.
- Phase II Comparator Study of Oral Versus Intravenous Topotecan in Patients With Chemosensitive Small-Cell Lung Cancer
- Progress of clinical oncology guidelines development using the Practice Guidelines Development Cycle: the role of practitioner feedback.
- Small-cell lung cancer: treatment progress and prospects.
- Chemotherapy for Relapsed Small Cell Lung Cancer: A Systematic Review and Practice Guideline
- Treatment of recurrent small cell lung cancer
- O-157 Survival benefit of oral topotecan plus supportive care versus supportive care alone in relapsed, resistant SCLC
- Topotecan in the Treatment of Relapsed Small Cell Lung Cancer Patients with Poor Performance Status